Sumitomo Mitsui Trust Group’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.25M Buy
11,300
+500
+5% +$48.3K ﹤0.01% 835
2026
Q2
$845K Hold
10,800
– – ﹤0.01% 901
2026
Q1
$698K Buy
10,800
+2,300
+27% +$162K ﹤0.01% 893
2025
Q4
$572K Buy
8,500
+4,100
+93% +$276K ﹤0.01% 930
2025
Q3
$323K Buy
+4,400
New +$292K ﹤0.01% 1005

Other funds holding HALO

Sumitomo Mitsui Trust Group's HALO Position: Q3 2026 in Review

Sumitomo Mitsui Trust Group increased its Halozyme (HALO) stake by 4.6% in Q3 2026, buying an estimated $48.3K and bringing the position to 11,300 shares worth $1.25M. The position accounts for ﹤0.01% of the portfolio, ranked #835.

Sumitomo Mitsui Trust Group first reported a position in HALO in Q3 2025 and has held it in 5 quarters since. 444 funds tracked by Wall St. Rank hold HALO as of Q3 2026.

  • Sumitomo Mitsui Trust Group held 11,300 shares of Halozyme worth $1.25M as of Q3 2026.
  • Sumitomo Mitsui Trust Group bought 500 Halozyme shares in Q3 2026, an estimated $48.3K.
  • Halozyme made up ﹤0.01% of Sumitomo Mitsui Trust Group's portfolio in Q3 2026, its #835 holding.
  • Sumitomo Mitsui Trust Group first reported a position in Halozyme in Q3 2025 and has held it in 5 quarters since.
  • 444 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q3 2026, filed 29 Oct 2026.